New pill joins fight against advanced stomach cancer in global trial
Disease control
Recruiting now
This global study is testing whether adding a new oral capsule called UTD2 to standard chemotherapy helps people with advanced stomach or gastroesophageal cancer live longer. It will involve about 778 adults who have not yet received drug treatment for their advanced cancer. The …
Phase: PHASE2, PHASE3 • Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC